Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†L A Renfro, A Grothey, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)T Ruers, C Punt, F Van Coevorden, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Carcinoid heart disease--a hidden complication of neuroendocrine tumoursI Dero, M De Pauw, I Borbath, et al.
European Radiology|July 12, 2015
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumoursS Van Binnebeek, B Vanbilloen, K Baete, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancerE Van Cutsem, H van de Velde, P Karasek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Critical Reviews in Oncology/Hematology|February 11, 2015
Pooled analysis of the surgical treatment for colorectal cancer liver metastasesG Veereman, J Robays, L Verleye, et al.
British Journal of Cancer|May 10, 2012
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cellsT Troiani, L Vecchione, E Martinelli, et al.
Pageof 23